-
ASSESSMENT OF FERTILITY AND INFERTILITY-RELATED KNOWLEDGE AMONG YOUNG ADULTS
Aug 11, 2026, 17:16 PM -
BURDEN OF DISEASE OF COPD GOLD 2-3 IN LATIN AMERICA: A MODEL-BASED ASSESSMENT OF MILD, MODERATE, AND SEVERE EXACERBATIONS
Aug 11, 2026, 17:16 PM -
PROJECTED IMPACT OF SEMAGLUTIDE ON HEALTHCARE RESOURCE UTILISATION IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
TRUST BEYOND EFFICIENCY: HUMAN-AI CONCORDANCE AS A KEY VALIDATION METRIC FOR AI-ENABLED SYSTEMATIC REVIEWS
Aug 11, 2026, 17:16 PM -
A BUDGET-NEUTRAL UTILIZATION-CREDIT INCENTIVE TO IMPROVE OPERATING ROOM CAPACITY MANAGEMENT: A PRE-POST STUDY
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN AND COST VARIATION OF PROSTHODONTIC REHABILITATION IN GREECE: A MICRO-COSTING STUDY FROM PRIVATE PRACTICE
Aug 11, 2026, 17:16 PM -
CONSISTENTLY ACCOUNTING FOR COSTS AND EFFECTS IN ECONOMIC EVALUATION AND HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
CLINICAL BURDEN OF COMPENSATED METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ESTIMATED VALUE OF OPTIMIZED TUMOR TREATING FIELDS DELIVERY IN NEWLY DIAGNOSED GLIOBLASTOMA: AN EXPLORATORY COST-UTILITY ANALYSIS
Aug 11, 2026, 17:16 PM -
MAINTAINING CONCEPTUAL EQUIVALENCE IN LINGUISTIC VALIDATION FOR LINGUISTICALLY UNDERSERVED LANGUAGES: CHALLENGES AND PRACTICAL SOLUTIONS FROM LAO, KHMER, TIGRINYA, AND KINYARWANDA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF THE BIVALENT RESPIRATORY SYNCYTIAL VIRUS PREFUSION F (RSVPREF) VACCINE IN AT-RISK ADULTS AGED =60 YEARS IN PERU
Aug 11, 2026, 17:16 PM -
COMPARATIVE ANALYSIS OF REGULATORY APPROVAL AND HTA EVALUATION FOR FDA-APPROVED ONCOLOGY THERAPIES ACROSS MFN-BASKET COUNTRIES
Aug 11, 2026, 17:16 PM -
DERIVING A LOCAL COST-EFFECTIVENESS THRESHOLD FROM DIALYSIS EXPENDITURE: IMPLICATIONS FOR RARE KIDNEY DISEASE REIMBURSEMENT
Aug 11, 2026, 17:16 PM -
THE USE AND REPORTING OF CONCEPTUAL MODELS FOR ATTRIBUTE DEVELOPMENT IN PREFERENCE RESEARCH - INSIGHTS FROM A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
SUB-OPTIMAL BIOCHEMICAL AND HEALTH RELATED QUALITY OF LIFE OUTCOMES WITH OFF-LABEL BEZAFIBRATE USE IN PATIENTS WITH PBC: ANALYSIS OF A REAL-WORLD DATASET
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESSOF THE SYMPLICITY SPYRAL™ RENAL DENERVATION SYSTEM IN ADULTS WITH UNCONTROLLED HYPERTENSION IN TURKIYE
Aug 11, 2026, 17:16 PM -
MEASURING ACTIVITY, NOT DELIVERY: RE-EXAMINING THE EU HTA REGULATION'S FOUNDING IMPACT ASSESSMENT
Aug 11, 2026, 17:16 PM -
LONG-TERM HEALTH OUTCOMES SIMULATION OF SERPLULIMAB FOR PD-L1-POSITIVE, LOCALLY ADVANCED, RESECTABLE GASTRIC/GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA PATIENTS IN CHINA
Aug 11, 2026, 17:16 PM -
A SIMULATION STUDY OF AREA-UNDER-THE CURVE MATCHING-ADJUSTED INDIRECT COMPARISON FOR ROBUST LONGITUDINAL TREATMENT EVALUATION
Aug 11, 2026, 17:16 PM -
REAL-WORLD DRIVERS OF CLINICAL DECISION-MAKING IN ATRIAL FIBRILLATION: UNDERSTANDING SUBJECTIVE REASONS FOR NON-INITIATION OF ORAL ANTICOAGULANTS
Aug 11, 2026, 17:16 PM
